Coronavirus disease 2019 and vaccination in patients with Shwachman‐Diamond syndrome

Because they can experience neutropenia due to bone marrow failure, patients with Shwachman‐Diamond syndrome (SDS) carry increased risk for serious infections compared with the general population; however, there has been a paucity of data on the incidence and severity of coronavirus disease 2019 (COVID‐19) in patients with SDS. We compiled results from a survey distributed to participants in the SDS Registry in May‐June 2021. In this report, we describe the characteristics and outcomes of patients with SDS who had COVID‐19. Patients reported a short clinical course without significant complications or cytopenias. Additionally, COVID‐19 vaccines were well tolerated with minor side effects.